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Abstract
Background: A 60-year-old man presented to the emergency department with a left eye orbital
rupture sustained during a fall due to syncope shortly after smoking more than his usual amount of
marijuana.
Case presentation: The patient reported experiencing a shock from his implantable
cardioverter-defibrillator (ICD) device prior to the loss of consciousness. There was no
biochemical, electrocardiographic, or clinical evidence of ischemia. ICD interrogation revealed one
episode of ventricular fibrillation which was appropriately sensed and treated with a single shock
of 35 Joules.
Conclusion: Although the cardiovascular effects of marijuana are usually well tolerated in young
healthy users, its use may trigger life-threatening arrhythmias in patients with structural heart
disease. To the best of our knowledge, this is the first report on a case of ventricular fibrillation
triggered by marijuana use in a patient with an ICD.
Background
Marijuana (Cannabis) is one of the most widely used
illicit drugs in North America [1]. Acute use is known to
cause dose-dependent tachycardia, raised blood pressure,
and increased cardiac output, however little is known
about its effects on cardiac conduction [2-4]. Acute expo-
sure has been linked to ventricular tachycardia (VT) in one
previous report [5]. We report the first case of ventricular
fibrillation (VF) occurring after more than usual exposure
to marijuana recorded by an implantable cardioverter-
defibrillator (ICD).
Case report
A 60-year-old male presented to the hospital following a
syncopal event that was preceded by an ICD shock shortly
after exposure to marijuana.
The patient has a past history significant for a large ante-
rior myocardial infarction and severe three-vessel coro-
nary artery disease (CAD). The patient was not deemed a
bypass candidate and has received a single chamber ICD
(Medtronic EnTrust D154VRC) for prevention of sudden
cardiac death (SCD) in context of a left ventricular ejec-
tion fraction of 20%.
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The patient presented to hospital on this occasion follow-
ing a left eye orbital rupture sustained during a fall due to
the syncopal event shortly after smoking 4 "bongs" of
marijuana. The patient experienced an ICD discharge
prior to the loss of consciousness. There were no other
associated symptoms. At no time did the patient have
clinical signs or symptoms of angina or cardiac failure.
The patient gives a history of experiencing an ICD dis-
charge while smoking the same amount of marijuana 6
months prior. With both occasions, the patient had used
4 bongs rather than his usual 2 to 3 bongs of smoking. He
did not seek medical attention at that time. Other than
these two episodes of ICD discharge following more than
his usual marijuana exposure, he denied any other syn-
cope or ICD discharge.
There was no family history of SCD. The patient was
receiving at home enteric coated aspirin 81 mg daily,
carvedilol 25 mg twice daily, ramipril 10 mg once daily,
atorvastatin 20 mg once daily, spironolactone 25 mg once
daily, furosemide 40 mg once daily, diazepam 10 mg once
daily, rabeprazole 10 mg as needed for heartburn, all
without any changes in the two months prior to this epi-
sode. He denied any other recreational drug, or alcohol
use. Home oxygen was used at night during sleep. The
patient reports use of marijuana daily using a water pipe.
He typically uses 7 or 8 "bongs" throughout the day, usu-
ally 2 to 3 "bongs" at one time. On the occasions that he
inhaled a fourth "bong" consecutively, his defibrillator
discharged.
Investigations revealed no biochemical or electrocardio-
graphic evidence of ischemia. Following repair of the
globe rupture, the ICD was interrogated and revealed one
event in the VF zone (rate > 188 bpm) which was ade-
quately detected and treated with one appropriate shock.
The device delivered anti-tachycardia pacing during charg-
ing and a 35 J shock (Figure 1) that was successful to
restore normal sinus rhythm. During the interrogation,
the device was reprogrammed to decrease the VT/VF detec-
tion from 12/16 to 6/8. The device was found to be other-
wise functioning normally. The patient made an
uneventful recovery and was discharged home after 2 days
of intravenous amiodarone therapy and was discharged
with a prescription for oral amiodarone and strong advice
of quit smoking.
Discussion
Although marijuana is the most frequently used illicit
drug worldwide, its effects on the cardiovascular system
remains controversial [6,7] (Table 1). In our case, the
patient described experiencing 2 syncopal events, each
occurring after more than his usual marijuana exposure.
Although this observation does not prove a cause-and-
effect relationship, the timing of the events suggests that
dose dependent marijuana exposure may have lead to
ventricular fibrillation in this patient with coronary artery
disease and structural heart disease. We hypothesize that
the arrhythmic event was triggered by excessive catecho-
lamine release. Gash et al assessed the effects of smoking
marijuana cigarettes containing 6 mg of delta-9-tetrahy-
drocannabinol in healthy men, using M-mode echocardi-
ography. [3] The authors observed an increase in heart
Stored electrogram from the ICD Figure 1
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rate and left ventricular performance (mean rate of inter-
nal diameter shortening) for at least 1 hour after drug
exposure compared to placebo cigarettes. After 39 min-
utes of marijuana exposure, plasma norepinephrine was
significantly raised compared to control values and those
after placebo cigarette use. Levels remained elevated for at
least 2 hours after exposure, and suggested excessive sym-
pathoadrenal discharge and prolonged catecholamine
release was triggered by marijuana use. The authors con-
cluded that marijuana had a positive inotropic effect on
the heart in healthy subjects. In contrast, Prakash et al
observed that marijuana use increased the heart rate and
systolic and diastolic blood pressure and decreased the
ejection fraction in men with CAD[4]. It has been sug-
gested that in such individuals, augmentation of heart rate
may lead to deterioration of left ventricular performance
[3,5]. We therefore hypothesize that in this patient with
significant heart disease, increased catecholamine release
following increased marijuana exposure triggered ven-
tricular fibrillation. The possibility remains that the
arrhythmia could be unrelated to marijuana exposure
however this seems unlikely as the events only occurred
shortly after a similar amount of exposure on 2 separate
occasions. The Naranjo score, a validated scoring tool to
determine adverse drug reaction probability, revealed a
probable relationship between marijuana and ventricular
fibrillation (score of 5). [8]
An alternative mechanism for arrhythmia has been postu-
lated in one previous report describing a case of ventricu-
lar tachycardia following habitual marijuana use. A
healthy 34 year old man presented with VT three hours
after smoking marijuana [5]. The patient underwent suc-
cessful electrical cardioversion. Coronary angiography
revealed normal epicardial vessels without stenosis; how-
ever a marked reduction in coronary flow was detected.
The clinical tachycardia was also inducible in the electro-
physiology laboratory. Following verapamil therapy, his
coronary flow normalized and VT was no longer induci-
ble. In this patient the VT had a right bundle-branch block
and left axis deviation morphology (Belhassen morphol-
ogy). The VT responded well to verapamil therapy. Mari-
juana may have played a role by enhancing triggered
activity in the Purkinje fibers. In our case, the clinical
manifestation was VF; thereby the physiopathology mech-
anism described for VT is less suitable.
Conclusion
It is strongly suspected that increased use of marijuana in
our patient with structural heart disease, lead to this syn-
copal event and ventricular fibrillation as recorded by the
patient's ICD. Chronic users of marijuana with known
structural heart disease should be cautioned on increasing
their habitual marijuana use.
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Table 1: Marijuana cardiovascular effects.
System affected Clinical implications Comments
Autonomic Nervous System: Increase 
norepinephrine release
Sinus tachycardia Hypertension Healthy volunteers
Increased sinus automaticity Sinus tachycardia Healthy volunteers
Facilitated conduction velocity Supraventricular and/or ventricular tachycardia, 
PVC
Healthy volunteers/structural heart disease
Vascular periphery: dysfunctional baroreceptor 
activity
Vasovagal syncope/hypotension
Coronary arteries Coronary artery disease (AMI) Controversial
Central Nervous system Stroke Controversial
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